---
title: FDA Regulations (21 CFR)
---

# FDA Regulations — 21 CFR

FDA medical device regulations are in **Title 21 of the Code of Federal Regulations (21 CFR)**. All regulations: [ecfr.gov/current/title-21](https://www.ecfr.gov/current/title-21).

## Key Parts Overview

| Part | Title | Key Requirement |
|------|-------|----------------|
| [21 CFR 801](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-801) | Labeling | Adequate directions for use, Rx-only labeling |
| [21 CFR 803](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-803) | Medical Device Reporting (MDR) | Mandatory reporting of deaths, serious injuries, malfunctions |
| [21 CFR 806](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-806) | Corrections and Removals | Reporting recalls and field corrections |
| [21 CFR 807](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-807) | Establishment Registration & Device Listing | 510(k) premarket notification |
| [21 CFR 812](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-812) | Investigational Device Exemptions (IDE) | Clinical studies with unapproved devices |
| [21 CFR 814](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-814) | Premarket Approval (PMA) | Class III device approval |
| [21 CFR 820](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-820) | Quality Management System Regulation (QMSR) | QMS aligned with ISO 13485:2016 |
| [21 CFR 830](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-830) | Unique Device Identification (UDI) | UDI labeling and GUDID database |

## 21 CFR Part 820 — QMSR Key Requirements (Effective Feb 2, 2026)

FDA updated Part 820 in 2024 to align with **ISO 13485:2016**, creating the **Quality Management System Regulation (QMSR)**.

- [Federal Register Notice](https://www.federalregister.gov/documents/2024/02/02/2024-01318/medical-devices-quality-system-regulation-amendments)
- Incorporates ISO 13485:2016 by reference
- Replaces the former Quality System Regulation (QSR)

**Key QMSR Subparts:**

| Subpart | Topic |
|---------|-------|
| Subpart A | General Provisions (scope, definitions) |
| Subpart B | Quality Management System (QMS planning, documentation) |
| Subpart C | Management Responsibility |
| Subpart D | Resource Management |
| Subpart E | Product and Service Realization (design controls, purchasing) |
| Subpart F | Measurement, Analysis and Improvement |

## 21 CFR Part 801 — Labeling Key Sections

- **801.4**: Adequate directions for use
- **801.15**: Prominence of required label statements
- **801.109**: Prescription devices — Rx-only labeling
- **801.119**: In vitro diagnostic products labeling

## 21 CFR Part 812 — IDE Key Sections

- **812.20**: Application for IDE
- **812.25**: Investigational plan (protocol, risk analysis, device description)
- **812.36**: Treatment IDE for serious/life-threatening conditions

## Premarket Submission Pathways

| Pathway | Regulation | Device Class | Description |
|---------|-----------|-------------|-------------|
| 510(k) | 21 CFR 807 Subpart E | Class II (most) | Substantial equivalence to predicate |
| De Novo | 21 CFR 860.260 | Class I/II (novel) | New classification for novel low-to-moderate risk devices |
| PMA | 21 CFR 814 | Class III | Premarket approval with clinical evidence |
| HDE | 21 CFR 814 Subpart H | Class III (rare disease) | Humanitarian Device Exemption |
| IDE | 21 CFR 812 | Investigational | Clinical study exemption |

::: tip
All 21 CFR regulations: [ecfr.gov/current/title-21](https://www.ecfr.gov/current/title-21)
:::
